FDA approves Alnylam's first-ever drug for rare kidney disease

FDA approves Alnylam's first-ever drug for rare kidney disease

Source: 
Bizjournals
snippet: 

Alnylam Pharmaceuticals Inc. has added another "first" to its list of accomplishments Monday when regulators approved its drug for a rare kidney disorder.